drugset / Trial / NCT04116151

Effectiveness of a Cream for Treatment of Dermatitis in Patients Whith Breast Cancer

NCT04116151 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

It is intended to evaluate the effect of a marketed cream (Alantel®) based on natural products at high concentrations for the preventive and curative treatment (early stages) of radiation-induced dermatitis in cancer patients. For this, an experimental, prospective, controlled clinical trial, with two parallel arms, double blind, multicentre, will be carried out in which doctors will recruit 78 patients aged 14 years or over in Primary Care consultations. more, diagnosed with cancer, and having received radiotherapeutic cancer treatment, being randomly assigned to the experimental group (cosmetic cream) or the control group (emollient and moisturizing cream). The main variable will be the incidence rate of mild post-translational dermatitis and its improvement or cure once it has been established.

Timeline

Start
2022-07-19
Primary completion
2023-05-30
Completion
2023-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Alantel Unknown — Topical

Indications